Rosiglitazone Inhibits Proliferation, Motility, and Matrix Metalloproteinase Production in Keratinocytes

Journal of Investigative Dermatology

Volumn 122, Issue 1, 2004, Pages 130-139

  Bhagavathula, Narasimharao ^a   Nerusu, Kamalakar C ^a   Lal, Ashish ^a   Ellis, Charles N ^a   Chittiboyina, Amar ^b   Avery, Mitchell A ^b   Ho, Christopher I ^c   Benson, Stephen C ^c   Pershadsingh, Harrihar A ^d,e   Kurtz, Theodore W ^f   Varani, James ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c CALIFORNIA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Bethesda Pharmaceuticals Inc   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epidermal growth factor; Hyperplasia; Peroxisome proliferator activated receptor gamma (PPAR gamma); Psoriasis; Thiazolinedione

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIMITOTIC AGENT; BP 11017; BP 1107; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PIOGLITAZONE; PROTEIN C JUN; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHOSPHORYLATION; CELL CULTURE; CELL MOTILITY; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME RELEASE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; KERATINOCYTE; ORGAN CULTURE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN; STATISTICAL SIGNIFICANCE;

EID: 9144237419     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202X.2003.22111.x     Document Type: Article

References (57)

1. Barrandon Y, Green H: Cell migration is essential for sustained growth of keratinocyte colonies: The roles of transforming growth factor-alpha and epidermal growth factor. Cell 50:1131-1137, 1987
2. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-771, 1988
3. Brauchle M, Gluck D, Di Padova F, Han J, Gram H: Independent role of p38 and ERK1/2 mitogen-activated kinases in the upregulation of matrix metalloproteinase-1. Exp Cell Res 258:135-144, 2000
4. Brunet A, Roux D, Lenormand P, Dowd S, Keyse S, Pouyssegur J: Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J 18:664-674, 1999
5. Chen P, Xie H, Sekar M, Gupta K, Wells A: Epidermal growth factor receptor-mediated cell motility: Phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol 127:847-857, 1994
6. Chung JH, Kang S, Varani J, Lin J, Fisher GJ, Voorhees JJ: Decreased extracellular-signal-regulated kinase and increased stress-activated MAP kinase activities in aged human skin in vivo. J Invest Dermatol 115:177-182, 2000
7. Cook PW, Piepkorn M, Clegg CH, Plowman GD, DeMay JM, Brown JR, Pittelkow MR: Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J Clin Invest 100:2286-2294, 1997
8. Cook PW, Pittelkow MR, Keeble WW, Graves-Deal R, Coffey RJ Jr, Shipley GD: Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas. Cancer Res 52:3224-3227, 1992
9. Elder JT, Fisher GJ, Lindquist PB, et al: Overexpression of transforming growth factor alpha in psoriatic epidermis. Science 243:811-814, 1989
10. Ellis CN, Varani J, Fisher GJ, et al: Troglitazone improves psoriasis and normalizes models of proliferative skin disease: Ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation. Arch Dermatol 136:609-616, 2000
11. Fisher GJ, Talwar HS, Lin J, et al: Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Invest 101:1432-1440, 1998
12. Fligiel SE, Varani J: In situ epithelial cell invasion in organ culture. Invasion Metastasis 13:225-233, 1993
13. Forman BM, Tontonoz P, Chen J, Brun RP, Spiegelman BM, Evans RM: 15-Deoxy-delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83:803-812, 1995
14. Fry L: Psoriasis. Br J Dermatol 119:445-461, 1988
15. Gibbs DF, Warner RL, Weiss SJ, Johnson KJ, Varani J: Characterization of matrix metalloproteinases produced by rat alveolar macrophages. Am J Respir Cell Mol Biol 20:1136-1144, 1999
16. Gonzalez F, Seth A, Raden D, Bowman D, Fay F, Davis R: Serum-induced translocation of mitogen-activated protein kinase to the cell surface ruffling membrane and the nucleus. J Cell Biol 122:1089-1101, 1993
17. Gottlieb AB, Chang CK, Posnett DN, Fanelli B, Tam JP: Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes. J Exp Med 167:670-675, 1988
18. Henry RR: Thiazolidinediones. Endocrinol Metab Clin North Am 26:553-573, 1997
19. Karin M, Liu Z, Zandi E: AP-1 function and regulation. Curr Opin Cell Biol 9:240-246, 1997
20. Khokhlatchev AV, Canagarajah B, Wilsbacher J, Robinson M, Atkinson M, Goldsmith E, Cobb MH: Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93:605-615, 1998
21. Klemke RL, Cai S, Giannini AL, Gallagher PJ, Lanerolle PD, Cheresh DA: Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137:481-492, 1997
22. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, Lehmann JM: A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83:813-819, 1995
23. Komuves LG, Hanley K, Lefebvre AM, et al: Stimulation of PPARalpha promotes epidermal keratinocyte differentiation in vivo. J Invest Dermatol 115:353-360, 2000
24. Krueger GG, Bergstresser PR, Lowe NJ, Voorhees JJ, Weinstein GD: Psoriasis. J Am Acad Dermatol 11:937-947, 1984
25. Kubota T, Koshizuka K, Williamson EA, et al: Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res 58:3344-3352, 1998
26. Lim M, Martinez T, Jablons D, et al: Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. FEBS Lett 441:88-92, 1998
27. Malhotra S, Safia N, Pandhi P, Kumar B, Jain R, Aggarwal M: Pioglitazone versus placebo in patients with plaque psoriasis pilot trail (the P6 trail): Study design and preliminary results. J Clin Pharmacol 42:1053 (1013A), 2002
28. Moon SE, Bhagavathula N, Varani J: Keratinocyte stimulation of matrix metalloproteinase-1 production and proliferation in fibroblasts: Regulation through mitogen-activated protein kinase signaling events. Br J Cancer 87:457-464, 2002
29. Mueller E, Sarraf P, Tontonoz P, et al: Terminal differentiation of human breast cancer through PPAR gamma. Mol Cell 1:465-470, 1998
30. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM: Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93:229-240, 1998
31. Nickoloff BJ, Mitra RS, Elder JT, Fisher GJ, Voorhees JJ: Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-alpha production in keratinocytes cultured from psoriatic lesions. Br J Dermatol 121:161-174, 1989
32. Nickoloff BJ, Mitra RS, Riser BL, Dixit VM, Varani J: Modulation of keratinocyte motility: Correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors. Am J Pathol 132:543-551, 1988
33. Nickoloff BJ, Mitra RS, Varani J, Dixit VM, Polverini PJ: Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol 144:820-828, 1994
34. Olefsky JM: Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. J Clin Invest 106:467-472, 2000
35. Piepkorn M, Pittelkow MR, Cook PW: Autocrine regulation of keratinocytes: The emerging role of heparin-binding, epidermal growth factor-related growth factors. J Invest Dermatol 111:715-721, 1998
36. Piepkorn M, Predd H, Underwood R, Cook P: Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes. Arch Dermatol Res 27:27, 2003
37. Pittelkow MR, Cook PW, Shipley GD, Derynck R, Coffey RJ Jr: Autonomous growth of human keratinocytes requires epidermal growth factor receptor occupancy. Cell Growth Differ 4:513-521, 1993
38. Reszka A, Seger R, Diltz C, Krebs E, Fischer E: Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc Natl Acad Sci USA 92:8881-8885, 1995
39. Reunanen N, Westermarck J, Hakkinen L, Holmstrom TH, Elo I, Eriksson JE, Kahari VM: Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene expression by ceramide is mediated by extracellular signal-regulated and stress-activated protein kinase pathways. J Biol Chem 273:5137-5145, 1998
40. Rivier M, Castiel I, Safonova I, Ailhaud G, Michel S: Peroxisome proliferator-activated receptor-alpha enhances lipid metabolism in a skin equivalent model. J Invest Dermatol 114:681-687, 2000
41. Rivier M, Safonova I, Lebrun P, Griffiths CE, Ailhaud G, Michel S: Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes. J Invest Dermatol 111:1116-1121, 1998
42. Sarraf P, Mueller E, Jones D, et al: Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat Med 4:1046-1052, 1998
43. Sawa M, Tsukamoto T, Kiyoi T, et al: New strategy for antedrug application: Development of metalloproteinase inhibitors as antipsoriatic drugs. J Med Chem 45:930-936, 2002
44. Varani J, Bendelow MJ, Sealey D, Gannon D, Ryan U, Kunkel SL, Ward PA: TNFα-induced susceptibility of endothelial cells to neutrophil-mediated killing. Lab Invest 59:292-295, 1988
45. Varani J, Fligiel SE, Schuger L, Perone P, Inman D, Griffiths CE, Voorhees JJ: Effects of all-trans retinoic acid and Ca++ on human skin in organ culture. Am J Pathol 142:189-198, 1993
46. Varani J, Fligiel SEG, Till GO, Kunkel RG, Ryan US, Ward PA: Pulmonary endothelial cell killing by human neutrophils: Possible involvement of hydroxyl radical. Lab Invest 53:656-663, 1985
47. Varani J, Hattori Y, Chi Y, et al: Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: Comparison with normal skin. Br J Cancer 82:657-665, 2000
48. Varani J, Hirschl RB, Dame M, Johnson K: Perfluorocarbon protects lung epithelial cells from neutrophil-mediated injury in an in vitro model of liquid ventilation therapy. Shock 6:339-344, 1996
49. Varani J, Kang S, Stoll S, Elder JT: Human psoriatic skin in organ culture: Comparison with normal skin exposed to exogenous growth factors and effects of an antibody to the EGF receptor. Pathobiology 66:253-259, 1998
50. Varani J, Perone P, Griffiths CE, Inman DR, Fligiel SE, Voorhees JJ: All-trans retinoic acid (RA) stimulates events in organ-cultured human skin that underlie repair: Adult skin from sun-protected and sun-exposed sites responds in an identical manner to RA while neonatal foreskin responds differently. J Clin Invest 94:1747-1756, 1994
51. Varani J, Zeigler M, Dame MK, et al: Heparin-binding epidermal-growth- factor-like growth factor activation of keratinocyte ErbB receptors mediates epidermal hyperplasia, a prominent side-effect of retinoid therapy. J Invest Dermatol 117:1335-1341, 2001
52. Westermarck J, Holmstrom T, Ahonen M, Eriksson JE, Kahari VM: Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38. Matrix Biol 17:547-557, 1998
53. Whisler RL, Chen M, Beiqing L, Carle KW: Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging. Cell Immunol 175:41-50, 1997
54. Willson TM, Brown PJ, Sternbach DD, Henke BR: The PPARs: From orphan receptors to drug discovery. J Med Chem 43:527-550, 2000
55. Zeigler ME, Chi Y, Schmidt T, Varani J: Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. J Cell Physiol 180:271-284, 1999
56. Zeigler ME, Dutcheshen NT, Gibbs DF, Varani J: Growth factor-induced epidermal invasion of the dermis in human skin organ culture: Expression and role of matrix metalloproteinases. Invasion Metastasis 16:11-18, 1996b
57. Zeigler ME, Krause S, Karmiol S, Varani J: Growth factor-induced epidermal invasion of the dermis in human skin organ culture: Dermal invasion correlated with epithelial cell motility. Invasion Metastasis 16:3-10, 1996a